↓ Skip to main content

Clinical approach to treatable inborn metabolic diseases: An introduction

Overview of attention for article published in Journal of Inherited Metabolic Disease, March 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

patent
1 patent
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
138 Dimensions

Readers on

mendeley
193 Mendeley
Title
Clinical approach to treatable inborn metabolic diseases: An introduction
Published in
Journal of Inherited Metabolic Disease, March 2006
DOI 10.1007/s10545-006-0358-0
Pubmed ID
Authors

J.‐M. Saudubray, F. Sedel, J. H. Walter

Abstract

In view of the major improvements in treatment, it has become increasingly important that in order for first-line physicians not to miss a treatable disorder they should be able initiate a simple method of clinical screening, particularly in the emergency room. We present a simplified classification of treatable inborn errors of metabolism in three groups. Group 1 includes inborn errors of intermediary metabolism that give rise to an acute or chronic intoxication. It encompasses aminoacidopathies, organic acidurias, urea cycle disorders, sugar intolerances, metal disorders and porphyrias. Clinical expression can be acute or systemic or can involve a specific organ, and can strike in the neonatal period or later and intermittently from infancy to late adulthood. Most of these disorders are treatable and require the emergency removal of the toxin by special diets, extracorporeal procedures, cleansing drugs or vitamins. Group 2 includes inborn errors of intermediary metabolism that affect the cytoplasmic and mitochondrial energetic processes. Cytoplasmic defects encompass those affecting glycolysis, glycogenosis, gluconeogenesis, hyperinsulinisms, and creatine and pentose phosphate pathways; the latter are untreatable. Mitochondrial defects include respiratory chain disorders, and Krebs cycle and pyruvate oxidation defects, mostly untreatable, and disorders of fatty acid oxidation and ketone bodies that are treatable. Group 3 involves cellular organelles and includes lysosomal, peroxisomal, glycosylation, and cholesterol synthesis defects. Among these, some lysosomal disorders can be efficiently treated by enzyme replacement or substrate reduction therapies. Physicians can be faced with the possibility of a treatable inborn error in an emergency, either in the neonatal period or late in infancy to adulthood, or as chronic and progressive symptoms--general (failure to thrive), neurological, or specific for various organs or systems. These symptoms are summarized in four tables. In addition, an extensive list of medications used in the treatment of inborn errors is presented.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 193 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
United Kingdom 2 1%
Netherlands 1 <1%
Brazil 1 <1%
Canada 1 <1%
Poland 1 <1%
Unknown 185 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 28 15%
Other 24 12%
Student > Bachelor 23 12%
Researcher 20 10%
Student > Master 20 10%
Other 47 24%
Unknown 31 16%
Readers by discipline Count As %
Medicine and Dentistry 79 41%
Agricultural and Biological Sciences 25 13%
Biochemistry, Genetics and Molecular Biology 23 12%
Neuroscience 10 5%
Nursing and Health Professions 5 3%
Other 17 9%
Unknown 34 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2016.
All research outputs
#4,695,994
of 22,785,242 outputs
Outputs from Journal of Inherited Metabolic Disease
#296
of 1,841 outputs
Outputs of similar age
#12,721
of 71,497 outputs
Outputs of similar age from Journal of Inherited Metabolic Disease
#6
of 25 outputs
Altmetric has tracked 22,785,242 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,841 research outputs from this source. They receive a mean Attention Score of 4.6. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 71,497 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.